Caroline Gordon1, 2, 3, Maame-Boatemaa Amissah-Arthur1, Mary Gayed1, 3, Sue Brown4,
Ian N. Bruce5, 6, David D'Cruz7, Benjamin Empson8, Bridget Griffiths9, David Jayne10, 11 …

Assessment of the pattern and extent of arterial involvement and measurement of current
disease activity are essential for the management of Takayasu arteritis (TA). Since there is …

Background The treatment of lupus nephritis (LN) remains problematic because the current
treatment regimen based on unspecific immunosuppressants such as steroids …

Sjögren's syndrome (SS) is a systemic progressive autoimmune disease characterized by a
complex pathogenesis requiring a predisposing genetic background and involving immune …

Abstract Introduction Primary Sjögren's syndrome (pSS) is an autoimmune disorder affecting
exocrine glands; however, a subgroup of pSS patients experience systemic extra-glandular …

Systemic lupus erythematosus (SLE) is a chronic, multisystem, autoimmune disease of
unknown etiology, whose hallmark is the production of autoantibodies. B cells are promising …

Objective To evaluate changes in salivary gland echostructure and vascularization after
rituximab treatment in patients with primary Sjögren's syndrome (SS). Methods Twenty‐eight …

As in previous years, the consensus group to consider the use of biological agents in the
treatment of rheumatic diseases met during the 11th Annual Workshop on Advances in …

Autoimmune diseases (ADs) represent a heterogeneous group of disorders that affect
specific target organs or multiple organ systems. These conditions share common …

Introduction Takayasu arteritis (TA) is a large vessel vasculitis involving the aorta and its
major branches. T cell-mediated autoimmunity is thought to play a major role in its …